Breaking News
Get 45% Off 0
😎 Watchlist Weekend: Copy legendary investors' portfolios to your watchlist in 1 click
Copy for FREE
Close

Intellia Therapeutics Inc (NTLA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Intellia Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8.50 +0.43    +5.33%
16/05 - Closed. Currency in USD
After Hours
8.32
-0.19
-2.23%
19:41:49 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,459,226
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 8.03 - 8.52
Intellia Therapeutics Inc 8.50 +0.43 +5.33%

Intellia Therapeutics Inc Company Profile

 
Get an in-depth profile of Intellia Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

403

Equity Type

ORD

Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company’s in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. It also focusses on the research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. The company has license and collaboration agreement with AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of various of B cell-mediated autoimmune diseases; ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer; and ReCode Therapeutics, Inc. to develop novel genomic medicines for the treatment of cystic fibrosis. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address 40 Erie Street Suite 130
Cambridge, 02139
United States
Phone 857 285 6200
Fax -

Top Executives

Name Age Since Title
Franciscus A. G. M. Verwiel 59 2017 Independent Chairman of the Board
John M. Leonard 64 2014 President, CEO & Director
Arthur M. Krieg 68 - Member of Scientific Advisory Board
Beverly L. Davidson - 2015 Member of Scientific Advisory Board
Fred E. Cohen 69 2019 Independent Director
Jesse L. Goodman 74 2018 Independent Director
William J. Chase 57 2023 Independent Director
Muna Bhanji 61 2022 Independent Director
Georgia Keresty 62 2021 Independent Director
Brian M. Goff 56 2024 Independent Director
Erik J. Sontheimer - - Founder & Member of Scientific Advisor Board
Andrew May - - Founder and Member of Scientific Advisor Board
Jennifer A. Doudna 61 2015 Founder & Member of Scientific Advisor Board
Rodolphe Barrangou - - Founder & Member of Scientific Advisor Board
Luciano Marraffini - - Founder & Member of Scientific Advisor Board
Derrick J. Rossi - 2015 Founder & Member of Scientific Advisor Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NTLA Comments

Write your thoughts about Intellia Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Michael miki
Michael miki Apr 29, 2025 3:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I just jumped in bedore the results
Michael miki
Michael miki Apr 29, 2025 3:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
earnings tomorrow - I trust Cathie Wood :-)
Chris Tiernan
Chris Tiernan Aug 13, 2024 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lol
Jameson Dunsford
Jameson Dunsford Aug 13, 2024 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
embarrassing pick lmao
Sawlaram Choudhary
Sawlaram Choudhary Jul 11, 2024 10:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy and hold 12 months target 50+
pcg upstate
pcg upstate Dec 15, 2021 8:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
then sold
pcg upstate
pcg upstate Dec 15, 2021 4:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
kathy wood must have bought
Salvador Escobargonzalez
Salvador Escobargonzalez Oct 08, 2021 2:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will recover to 156! Mark my words as of Oct 9th!
pcg upstate
pcg upstate Oct 08, 2021 2:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice try, it's slowly moving up tho
Mahmood Ahmed
Mahmood Ahmed Oct 08, 2021 2:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
are you still there?
Richard Jung
Richard Jung Aug 05, 2021 7:33PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Miss on earnings and revenue but get a $33 peak bump in share price. what did I miss?
Vaishnavi Kabadi
Vaishnavi Kabadi Aug 05, 2021 7:33PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
results of thier studies
doc gramps
doc gramps Jul 21, 2021 5:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to buy a few and hold me thinks
Alisher Leo
Alisher Leo Jul 06, 2021 11:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any thought about this stock?
Danny Ahmad
Danny Ahmad Jul 06, 2021 11:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get some options
doc gramps
doc gramps Jul 01, 2021 11:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
waiting to get back in
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email